204 related articles for article (PubMed ID: 38117899)
1. Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with
Borna Š; Lee E; Nideffer J; Ramachandran A; Wang B; Baker J; Mavers M; Lakshmanan U; Narula M; Garrett AK; Schulze J; Olek S; Marois L; Gernez Y; Bhatia M; Chong HJ; Walter J; Kitcharoensakkul M; Lang A; Cooper MA; Bertaina A; Roncarolo MG; Meffre E; Bacchetta R
Sci Transl Med; 2023 Dec; 15(727):eadg6822. PubMed ID: 38117899
[TBL] [Abstract][Full Text] [Related]
2. Identification of FOXP3-negative regulatory T-like (CD4(+)CD25(+)CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Otsubo K; Kanegane H; Kamachi Y; Kobayashi I; Tsuge I; Imaizumi M; Sasahara Y; Hayakawa A; Nozu K; Iijima K; Ito S; Horikawa R; Nagai Y; Takatsu K; Mori H; Ochs HD; Miyawaki T
Clin Immunol; 2011 Oct; 141(1):111-20. PubMed ID: 21802372
[TBL] [Abstract][Full Text] [Related]
3. Defective regulatory and effector T cell functions in patients with FOXP3 mutations.
Bacchetta R; Passerini L; Gambineri E; Dai M; Allan SE; Perroni L; Dagna-Bricarelli F; Sartirana C; Matthes-Martin S; Lawitschka A; Azzari C; Ziegler SF; Levings MK; Roncarolo MG
J Clin Invest; 2006 Jun; 116(6):1713-22. PubMed ID: 16741580
[TBL] [Abstract][Full Text] [Related]
4. Demethylation analysis of the FOXP3 locus shows quantitative defects of regulatory T cells in IPEX-like syndrome.
Barzaghi F; Passerini L; Gambineri E; Ciullini Mannurita S; Cornu T; Kang ES; Choe YH; Cancrini C; Corrente S; Ciccocioppo R; Cecconi M; Zuin G; Discepolo V; Sartirana C; Schmidtko J; Ikinciogullari A; Ambrosi A; Roncarolo MG; Olek S; Bacchetta R
J Autoimmun; 2012 Feb; 38(1):49-58. PubMed ID: 22264504
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular characteristics of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China.
An YF; Xu F; Wang M; Zhang ZY; Zhao XD
Scand J Immunol; 2011 Sep; 74(3):304-309. PubMed ID: 21595732
[TBL] [Abstract][Full Text] [Related]
6. Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.
Passerini L; Di Nunzio S; Gregori S; Gambineri E; Cecconi M; Seidel MG; Cazzola G; Perroni L; Tommasini A; Vignola S; Guidi L; Roncarolo MG; Bacchetta R
Eur J Immunol; 2011 Apr; 41(4):1120-31. PubMed ID: 21400500
[TBL] [Abstract][Full Text] [Related]
7. FOXP3 deficiency, from the mechanisms of the disease to curative strategies.
Borna S; Meffre E; Bacchetta R
Immunol Rev; 2024 Mar; 322(1):244-258. PubMed ID: 37994657
[TBL] [Abstract][Full Text] [Related]
8. Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis.
Santoni de Sio FR; Passerini L; Restelli S; Valente MM; Pramov A; Maccari ME; Sanvito F; Roncarolo MG; Porteus M; Bacchetta R
J Allergy Clin Immunol; 2018 Dec; 142(6):1909-1921.e9. PubMed ID: 29705245
[TBL] [Abstract][Full Text] [Related]
9. IPEX and the role of Foxp3 in the development and function of human Tregs.
Le Bras S; Geha RS
J Clin Invest; 2006 Jun; 116(6):1473-5. PubMed ID: 16741571
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation.
Narula M; Lakshmanan U; Borna S; Schulze JJ; Holmes TH; Harre N; Kirkey M; Ramachandran A; Tagi VM; Barzaghi F; Grunebaum E; Upton JEM; Hong-Diep Kim V; Wysocki C; Dimitriades VR; Weinberg K; Weinacht KG; Gernez Y; Sathi BK; Schelotto M; Johnson M; Olek S; Sachsenmaier C; Roncarolo MG; Bacchetta R
J Allergy Clin Immunol; 2023 Jan; 151(1):233-246.e10. PubMed ID: 36152823
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome.
De Benedetti F; Insalaco A; Diamanti A; Cortis E; Muratori F; Lamioni A; Carsetti R; Cusano R; De Vito R; Perroni L; Gambarara M; Castro M; Bottazzo GF; Ugazio AG
Clin Gastroenterol Hepatol; 2006 May; 4(5):653-9. PubMed ID: 16630773
[TBL] [Abstract][Full Text] [Related]
12. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients.
Passerini L; Barzaghi F; Curto R; Sartirana C; Barera G; Tucci F; Albarello L; Mariani A; Testoni PA; Bazzigaluppi E; Bosi E; Lampasona V; Neth O; Zama D; Hoenig M; Schulz A; Seidel MG; Rabbone I; Olek S; Roncarolo MG; Cicalese MP; Aiuti A; Bacchetta R
J Allergy Clin Immunol; 2020 Apr; 145(4):1262-1271.e13. PubMed ID: 31874182
[TBL] [Abstract][Full Text] [Related]
13. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome.
Zhan H; Sinclair J; Adams S; Cale CM; Murch S; Perroni L; Davies G; Amrolia P; Qasim W
Pediatrics; 2008 Apr; 121(4):e998-1002. PubMed ID: 18316354
[TBL] [Abstract][Full Text] [Related]
14. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases.
Verbsky JW; Chatila TA
Curr Opin Pediatr; 2013 Dec; 25(6):708-14. PubMed ID: 24240290
[TBL] [Abstract][Full Text] [Related]
15. Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome.
Gambineri E; Ciullini Mannurita S; Hagin D; Vignoli M; Anover-Sombke S; DeBoer S; Segundo GRS; Allenspach EJ; Favre C; Ochs HD; Torgerson TR
Front Immunol; 2018; 9():2411. PubMed ID: 30443250
[No Abstract] [Full Text] [Related]
16. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
Mayer CT; Tian L; Hesse C; Kühl AA; Swallow M; Kruse F; Thiele M; Gershwin ME; Liston A; Sparwasser T
J Autoimmun; 2014 May; 50():23-32. PubMed ID: 24075450
[TBL] [Abstract][Full Text] [Related]
17. IPEX as a result of mutations in FOXP3.
van der Vliet HJ; Nieuwenhuis EE
Clin Dev Immunol; 2007; 2007():89017. PubMed ID: 18317533
[TBL] [Abstract][Full Text] [Related]
18. A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells.
Van Gool F; Nguyen MLT; Mumbach MR; Satpathy AT; Rosenthal WL; Giacometti S; Le DT; Liu W; Brusko TM; Anderson MS; Rudensky AY; Marson A; Chang HY; Bluestone JA
Immunity; 2019 Feb; 50(2):362-377.e6. PubMed ID: 30709738
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity.
Gambineri E; Perroni L; Passerini L; Bianchi L; Doglioni C; Meschi F; Bonfanti R; Sznajer Y; Tommasini A; Lawitschka A; Junker A; Dunstheimer D; Heidemann PH; Cazzola G; Cipolli M; Friedrich W; Janic D; Azzi N; Richmond E; Vignola S; Barabino A; Chiumello G; Azzari C; Roncarolo MG; Bacchetta R
J Allergy Clin Immunol; 2008 Dec; 122(6):1105-1112.e1. PubMed ID: 18951619
[TBL] [Abstract][Full Text] [Related]
20. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells.
Torgerson TR; Ochs HD
J Allergy Clin Immunol; 2007 Oct; 120(4):744-50; quiz 751-2. PubMed ID: 17931557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
